» Articles » PMID: 24237358

Changes in Masticatory Function After Injection of Botulinum Toxin Type A to Masticatory Muscles

Overview
Journal J Oral Rehabil
Specialty Dentistry
Date 2013 Nov 19
PMID 24237358
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This study examined changes in masticatory function after botulinum toxin type A (BTX-A) injection using objective and subjective tests during 12 weeks. Also, we compared differences in masticatory function between group in which only masseter muscle (M group) was injected and group in which masseter and temporal muscle (M-T group) were injected. Forty subjects were assigned into two groups; M group (n = 20) and the M-T group (n = 20). The Meditoxin(®) was used as BTX-A injection. The mixing ability index (MAI) was used as the objective indicator, and visual analogue scale (VAS) and food intake ability (FIA) index were used as subjective indicators. Overall, the masticatory function drastically declined after 4 weeks and gradually recovered with time. Compared with the pre-injection state, the masticatory function decreased by 89·2% (MAI), 12·2% (FIA) and 32·2% (VAS) 4 weeks after the injection (P < 0·05). When the results between M group and M-T group were compared, scores of VAS and FIA were significantly different 4 weeks after the injection (P < 0·05), but the MAI score showed no significant difference between two groups. In conclusion, this study showed that masticatory function was significantly decreased after BTX-A injection into the masticatory muscle after 4 and 8 weeks from injection. However, masticatory efficiency measured using MAI could completely recover after 12 weeks. Furthermore, after 8 weeks from the injection, the masticatory function measured after injection into only the masseter muscle was similar to that measured after injection into both masseter and temporal muscle.

Citing Articles

Botulinum toxin for bruxism treatment: a nationwide study among oral and maxillofacial surgeons in Germany.

Pabst A, Kammerer P, Heimes D, Zeller A, Quarta M Clin Oral Investig. 2024; 28(9):501.

PMID: 39186088 DOI: 10.1007/s00784-024-05898-7.


Histomorphometric Changes of the Masseter Muscle of Rats After a Single Injection of Botulinum Toxin Type A.

Ramos D, de Brito Silva R, De la Torre Canales G, Resende L, Esquisatto M, Moreira N Aesthetic Plast Surg. 2023; 48(5):1037-1044.

PMID: 37620565 DOI: 10.1007/s00266-023-03572-z.


Influential Factors of Masticatory Performance in Older Adults: A Cross-Sectional Study.

Kim H Int J Environ Res Public Health. 2021; 18(8).

PMID: 33919497 PMC: 8072885. DOI: 10.3390/ijerph18084286.


Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial.

De la Torre Canales G, Alvarez-Pinzon N, Munoz-Lora V, Peroni L, Farias Gomes A, Sanchez-Ayala A Toxins (Basel). 2020; 12(6).

PMID: 32549196 PMC: 7354430. DOI: 10.3390/toxins12060395.


Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects?.

De la Torre Canales G, Lorenzi Poluha R, Lora V, Ferreira D, Stuginski-Barbosa J, Bonjardim L Clin Oral Investig. 2019; 23(9):3411-3421.

PMID: 31342244 DOI: 10.1007/s00784-019-03026-4.